ALPMF
PINK Astellas Pharma Inc.$16.50 ↑ +2.55 (+18.28%) Trading Up from the previous close of $13.95, and at the day’s high of $16.50
- YTD change
- +25.28%
- vs 20-day SMA
- +11.85%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-0.75 (-4.35%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 7.6% away from all-time highs of $17.85
- ALPMF is up 25% since the beginning of the year
- ALPMF is up 68% over the past 12 months
- ALPMF is up 3% over the past 1 month
- 0% of all ALPMF investors are betting against ALPMF
ALPMF reads n/a: the 12-month move is +51.4%.
- Previous minute
- +$0.00
- Last hour
- +$2.40
- Last 5 days
- +7.49%
- vs 8-day SMA
- +17.21%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.